(Q38042443)

27 August 2017

title

Review article: the reversibility of cirrhosis (English)

1 reference

27 August 2017

1 reference

M Mohamadnejad

2

0 references

Reza Malekzadeh

object named as

R Malekzadeh

series ordinal

3

0 references

author name string

A A Sohrabpour

series ordinal

1

1 reference

27 August 2017

language of work or name

English

0 references

publication date

1 November 2012

1 reference

Alimentary Pharmacology & Therapeutics

27 August 2017

published in

1 reference

27 August 2017

volume

36

1 reference

27 August 2017

issue

9

1 reference

27 August 2017

page(s)

824-832

1 reference

Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis

27 August 2017

cites work

1 reference

21 January 2018

1 reference

Mechanisms of hepatic fibrogenesis

21 January 2018

1 reference

Portal fibroblasts: Underappreciated mediators of biliary fibrosis

21 January 2018

1 reference

Mechanisms of fibrogenesis

21 January 2018

1 reference

Epithelial-to-mesenchymal transitions in the liver

21 January 2018

1 reference

Nerves and perisinusoidal cells in human liver

21 January 2018

1 reference

The chemokine CCL21 modulates lymphocyte recruitment and fibrosis in chronic hepatitis C.

21 January 2018

1 reference

Fibrosis in chronic liver diseases: diagnosis and management

21 January 2018

1 reference

Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal

21 January 2018

1 reference

21 January 2018

1 reference

Sources of variability in histological scoring of chronic viral hepatitis

21 January 2018

1 reference

Current status of novel antifibrotic therapies in patients with chronic liver disease

21 January 2018

1 reference

Serum hyaluronate as a non-invasive marker of hepatic fibrosis and inflammation in HBeAg-negative chronic hepatitis B.

21 January 2018

1 reference

Serum markers detect the presence of liver fibrosis: a cohort study.

21 January 2018

1 reference

The role of the coupling term in transient elastography.

21 January 2018

1 reference

Learning curve and interobserver reproducibility evaluation of liver stiffness measurement by transient elastography.

21 January 2018

1 reference

Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease

21 January 2018

1 reference

Magnetic resonance imaging of hepatic fibrosis: emerging clinical applications

21 January 2018

1 reference

MR imaging of liver fibrosis: current state of the art.

21 January 2018

1 reference

Composition of inflammatory infiltrate and its correlation with HBV/HCV antigen expression.

21 January 2018

1 reference

The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection

21 January 2018

1 reference

Liver biopsy findings in chronic hepatitis B.

21 January 2018

1 reference

Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors

21 January 2018

1 reference

Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B

21 January 2018

1 reference

Decreasing fibrogenesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B.

21 January 2018

1 reference

Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B.

21 January 2018

1 reference

Reversibility of cirrhosis in chronic hepatitis B.

21 January 2018

1 reference

Lamivudine treatment in patients with severely decompensated cirrhosis due to replicating hepatitis B infection

21 January 2018

1 reference

Lamivudine for patients with chronic hepatitis B and advanced liver disease

21 January 2018

1 reference

Histological outcome during long-term lamivudine therapy.

21 January 2018

1 reference

Extended lamivudine treatment in patients with HBeAg-negative chronic hepatitis B.

21 January 2018

1 reference

Telbivudine versus lamivudine in patients with chronic hepatitis B

21 January 2018

1 reference

Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B.

21 January 2018

1 reference

A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B.

21 January 2018

1 reference

Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B.

21 January 2018

1 reference

Entecavir for Treatment of Lamivudine-Refractory, HBeAg-Positive Chronic Hepatitis B

21 January 2018

1 reference

Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years

21 January 2018

1 reference

Chronic hepatitis B: update 2009

21 January 2018

1 reference

Reversibility of hepatitis C virus-related cirrhosis

21 January 2018

1 reference

Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: A 5-year follow-up of 150 patients

21 January 2018

1 reference

Long term clinical outcome of chronic hepatitis C patients with sustained virological response to interferon monotherapy.

21 January 2018

1 reference

Effect of peginterferon alfa-2a on liver histology in chronic hepatitis C: a meta-analysis of individual patient data

21 January 2018

1 reference

Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.

21 January 2018

1 reference

Sustained virologic response prevents the development of esophageal varices in compensated, Child-Pugh class A hepatitis C virus-induced cirrhosis. A 12-year prospective follow-up study

21 January 2018

1 reference

EASL Clinical Practice Guidelines: management of hepatitis C virus infection

21 January 2018

1 reference

Hepatitis C: move over interferon

21 January 2018

1 reference

Impact of immunosuppressive treatment on liver fibrosis in autoimmune hepatitis

21 January 2018

1 reference

Resolution of cirrhosis in autoimmune hepatitis with corticosteroid therapy

21 January 2018

1 reference

Reversibility of cirrhosis in autoimmune hepatitis

21 January 2018

1 reference

Pathogenesis of non-alcoholic steatohepatitis: human data

21 January 2018

1 reference

Histological course of nonalcoholic fatty liver disease in Japanese patients: tight glycemic control, rather than weight reduction, ameliorates liver fibrosis

21 January 2018

1 reference

A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis

21 January 2018

1 reference

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

21 January 2018

1 reference

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

21 January 2018

1 reference

Long-term management of alcoholic liver disease

21 January 2018

1 reference

Reversibility of hepatic fibrosis in treated genetic hemochromatosis: a study of 36 cases.

21 January 2018

1 reference

Evolving challenges in hepatic fibrosis

21 January 2018

1 reference

Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis

21 January 2018

1 reference

Inhibition of PDGF, TGF-β, and Abl signaling and reduction of liver fibrosis by the small molecule Bcr-Abl tyrosine kinase antagonist Nilotinib.

21 January 2018

1 reference

Anti-fibrogenic strategies and the regression of fibrosis

21 January 2018

1 reference

Attenuated hepatic inflammation and fibrosis in angiotensin type 1a receptor deficient mice

21 January 2018

1 reference

TLR4 enhances TGF-beta signaling and hepatic fibrosis

21 January 2018

1 reference

LPS signaling enhances hepatic fibrogenesis caused by experimental cholestasis in mice.

21 January 2018

1 reference

Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis

21 January 2018

1 reference

Antiangiogenic treatment with sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats.

21 January 2018

1 reference

The bone marrow functionally contributes to liver fibrosis.

21 January 2018

1 reference

Bone marrow-derived mesenchymal stem cells protect against experimental liver fibrosis in rats

21 January 2018

1 reference

Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice

21 January 2018

1 reference

Intravenous injection of mesenchymal stem cells is effective in treating liver fibrosis

21 January 2018

1 reference

Critical review of clinical trials of bone marrow stem cells in liver disease.

21 January 2018

1 reference

Phase 1 human trial of autologous bone marrow-hematopoietic stem cell transplantation in patients with decompensated cirrhosis

21 January 2018

1 reference

The psychiatric side-effects of rimonabant

21 January 2018

1 reference

Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2.

21 January 2018

1 reference

Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment

21 January 2018

1 reference

Direct and indirect evidence for the reversibility of cirrhosis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/APT.12044

1 reference

27 August 2017

1 reference